Find More Contacts for Guardant Health
Protected Content
Chief Commercial Officer, Sales Professional
Non-Management, Executive Management
1 email found 2 phone numbers found
View contacts for Guardant Health to access new leads and connect with decision-makers.
View All Contacts
  • Number of Exits 
  • Contact Email press@guardanthealth.com
  • Phone Number 650-290-7575

Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that address long-standing unmet needs in oncology. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and rare-cell

diagnostics, and is closely advised by an oncologist-led medical steering committee from leading cancer centers across North America and abroad.

Lists Featuring This Company

West Coast Companies that Exited (Top 10K)
9,885 Number of Organizations â€¢ $976.2B Total Funding Amount â€¢ 42,077 Number of Investors
Investors Active in Seoul-t'ukpyolsi
2,302 Number of Organizations â€¢ $198.5B Total Funding Amount â€¢ 2,319 Number of Investors
Silicon Valley Public Companies With More Than $50M in Revenue
176 Number of Organizations â€¢ $227.8B Total Funding Amount â€¢ 1,438 Number of Investors
Investors Active in Asia (Top 10K)
9,593 Number of Organizations â€¢ $1.8T Total Funding Amount â€¢ 21,548 Number of Investors

Frequently Asked Questions

Where is Guardant Health's headquarters? Guardant Health is located in Redwood City, California, United States.Who invested in Guardant Health? Guardant Health has 28 investors including Baillie Gifford and Musea Ventures.How much funding has Guardant Health raised to date? Guardant Health has raised .When was the last funding round for Guardant Health? Guardant Health closed its last funding round on Dec 21, 2023 from a Post-IPO Equity round.Who are Guardant Health's competitors? Alternatives and possible competitors to Guardant Health may include Interius BioTherapeuticsTmunity Therapeutics, and Excision BioTherapeutics.